Skip to main content

Closed

CHRS: Coherus Oncology, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-362.1%

ROIC-125.2%

Financially safe

Stretched

Debt / equity0.69×

Interest coverage-18.8×

Current ratio1.56×

Coherus Oncology, Inc.

CHRSNASDAQ Global Market·USD·Closed

Coherus Oncology, Inc.

CHRSNASDAQ·USD·Closed

$1.41

−4.08%

$1.41

−$0.06 (4.08%)

52W Range

33thpctl

Volume

0.42×avg

Mkt Cap

172.60MUSD

P/E

-1.1TTM

Div Yield

–ann

52W Range

33thpctl

Volume

0.42×avg

Market Cap

172.60MUSD

P/E Ratio

-1.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings